Actinium Pharmaceuticals Inc (ATNM)
8.87
-0.82
(-8.46%)
USD |
NYAM |
May 21, 16:00
8.87
0.00 (0.00%)
After-Hours: 18:19
Actinium Pharmaceuticals Cash and Short Term Investments (Quarterly): 84.06M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 84.06M |
December 31, 2023 | 76.68M |
September 30, 2023 | 82.98M |
June 30, 2023 | 91.28M |
March 31, 2023 | 94.52M |
December 31, 2022 | 108.91M |
September 30, 2022 | 111.82M |
June 30, 2022 | 116.33M |
March 31, 2022 | 72.02M |
December 31, 2021 | 77.83M |
September 30, 2021 | 82.03M |
June 30, 2021 | 81.91M |
March 31, 2021 | 72.25M |
December 31, 2020 | 63.56M |
September 30, 2020 | 48.23M |
June 30, 2020 | 53.47M |
March 31, 2020 | 5.942M |
December 31, 2019 | 9.254M |
September 30, 2019 | 14.31M |
June 30, 2019 | 19.52M |
March 31, 2019 | 9.925M |
December 31, 2018 | 13.67M |
September 30, 2018 | 14.81M |
June 30, 2018 | 21.47M |
March 31, 2018 | 26.76M |
Date | Value |
---|---|
December 31, 2017 | 17.40M |
September 30, 2017 | 20.54M |
June 30, 2017 | 11.46M |
March 31, 2017 | 17.09M |
December 31, 2016 | 20.52M |
September 30, 2016 | 15.53M |
June 30, 2016 | 20.46M |
March 31, 2016 | 22.21M |
December 31, 2015 | 25.64M |
September 30, 2015 | 24.77M |
June 30, 2015 | 25.97M |
March 31, 2015 | 19.30M |
December 31, 2014 | 6.718M |
September 30, 2014 | 11.75M |
June 30, 2014 | 14.67M |
March 31, 2014 | 5.878M |
December 31, 2013 | 5.539M |
September 30, 2013 | 3.990M |
June 30, 2013 | 5.650M |
March 31, 2013 | 3.240M |
December 31, 2012 | 5.619M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.0001M |
March 31, 2012 | 0.0001M |
December 31, 2011 | 5.704M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.942M
Minimum
Mar 2020
116.33M
Maximum
Jun 2022
68.34M
Average
77.25M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Perspective Therapeutics Inc | 180.65M |
Eli Lilly and Co | 2.586B |
Cellectar Biosciences Inc | 40.03M |
Outlook Therapeutics Inc | 47.23M |
Bristol-Myers Squibb Co | 9.67B |